Heike Woehling

The EGALITY study: a confirmatory, randomized, double-blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate-to-severe chronic plaque-type psoriasis

C.E.M. Griffiths, Diamant Thaçi, Sascha Gerdes et al. · British Journal of Dermatology · 2017 · 181 citations · Full text

Medicine, Dermatology, Pharmacotherapy +12

Multiple switches between <scp>GP</scp>2015, an etanercept biosimilar, with originator product do not impact efficacy, safety and immunogenicity in patients with chronic plaque‐type psoriasis: 30‐week results from the phase 3, confirmatory <scp>EGALITY</scp> study

Sascha Gerdes, Diamant Thaçi, C.E.M. Griffiths et al. · Journal of the European Academy of Dermatology and Venereology · 2017 · 74 citations · Full text

Medicine, Dermatology, Pharmacology +12

Switching From Originator to Biosimilar Human Growth Hormone Using Dialogue Teamwork: Single-Center Experience From Sweden

Carl‐Erik Flodmark, Katarina Lilja, Heike Woehling et al. · Biologics in Therapy · 2013 · 43 citations · Full text

Medicine, Endocrinology, Pediatrics +13

Efficacy, safety and immunogenicity of GP2015, an etanercept biosimilar, compared with the reference etanercept in patients with moderate-to-severe rheumatoid arthritis: 24-week results from the comparative phase III, randomised, double-blind EQUIRA study

Marco Matucci‐Cerinic, Yannick Allanore, Arthur Kavanaugh et al. · RMD Open · 2018 · 41 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

GP2015, a proposed etanercept biosimilar: Pharmacokinetic similarity to its reference product and comparison of its autoinjector device with prefilled syringes

Oliver von Richter, Andrej Skerjanec, Miguel Afonso Filipe et al. · British Journal of Clinical Pharmacology · 2016 · 33 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13